SCHEMBL6817796

SCHEMBL6817796

CCNS(=O)(=O)c1cc2c(C(=O)Nc3ccc(C#N)cc3C(=O)O)noc2cc1-c1cccnc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.37
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
ALB P02768 2/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
BRD4 O60885 1/20 0.35
ATR Q13535 1/20 0.35
GAK O14976 1/20 0.34
STK16 O75716 1/20 0.34
PIM1 P11309 1/20 0.34
AXL P30530 1/20 0.34
NEK2 P51955 1/20 0.34
STK3 Q13188 1/20 0.34
STK11 Q15831 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
BMP2K Q9NSY1 1/20 0.34
TNIK Q9UKE5 1/20 0.34
NEK1 Q96PY6 1/20 0.34
LRRK2 Q5S007 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6819061 0.93 ALB (0.38) GSK3AGSK3BALBBRD4ALDH1A1
SCHEMBL6818975 0.92 PPARG (0.38) PPARGGSK3AGSK3BALBCYP11B1
SCHEMBL6817479 0.92 ALB (0.37) PPARGGSK3AGSK3BALBBRD4
SCHEMBL6817333 0.88 PPARG (0.39) PPARGGSK3AGSK3BALBCYP11B1
SCHEMBL6822331 0.86 BRD4 (0.39) GSK3AGSK3BALBBRD4LRRK2
SCHEMBL6818640 0.86 PPARG (0.39) PPARGGSK3AGSK3BALBCYP11B1
SCHEMBL6821670 0.84 HIF1A (0.41) ALBBRD4LRRK2ALDH1A1NR3C2
SCHEMBL6819285 0.84 ALB (0.40) GSK3AGSK3BALBBRD4ALDH1A1
SCHEMBL6818871 0.84 DHODH (0.42) PPARGGSK3AGSK3BALBCYP11B1
SCHEMBL6818761 0.83 ALB (0.39) PPARGGSK3AGSK3BALBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed